Article(id=1321425695838945779, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1321425656810951355, articleNumber=null, orderNo=null, doi=10.20251/j.cnki.1003-3734.2026.10.004, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=null, receivedDateStr=null, revisedDate=null, revisedDateStr=null, acceptedDate=1751731200000, acceptedDateStr=2025-07-06, onlineDate=1792982036790, onlineDateStr=2026-10-26, pubDate=1780070400000, pubDateStr=2026-05-30, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1792982036790, onlineIssueDateStr=2026-10-26, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1792982036790, creator=13701087609, updateTime=1792982036790, updator=13701087609, issue=Issue{id=1321425656810951355, tenantId=1146029695717560320, journalId=1235980733773295621, year='2026', volume='35', issue='10', pageStart='1009', pageEnd='1120', issueExtLink='null', onlineDate='null', pubDate='1780070400000', pubDateStr='2026-05-30', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1792982027485, creator='13701087609', updateTime=1792983064574, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1321430006727820106, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1321425656810951355, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1321430006727820107, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1321425656810951355, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1032, endPage=1039, ext={EN=ArticleExt(id=1321425695994135028, articleId=1321425695838945779, tenantId=1146029695717560320, journalId=1235980733773295621, language=EN, title=A comparative study of the implementation effects of breakthrough therapeutic drug systems in China and the United States, columnId=null, journalTitle=Chinese Journal of New Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=
Objective:

To draw on the useful experience of the breakthrough therapy designation (BTD) system in the United States (US) to provide suggestions and references for improving the BTD system in China.

Methods:

Through a comparative analysis of the implementation effects of the BTD systems in China and the US, the implementation effects and gaps of the BTD systems in the two countries were revealed.

Results & Conclusion:

The numbers of applications for BTD recognition in China and the US were generally on the rise, but the rates of BTD recognition and approval in China were significantly lower than those in the US, which may be related to the uneven quality of the applications and the lack of policy refinement. China's BTD drugs had a shorter pre-market clinical development time, but a longer review time, reflecting the difference in the strength of clinical trial guidance between the two countries' drug regulatory agencies. In terms of clinical trial design for antitumour drugs, China preferred single-arm, non-randomised design with objective remission rate as the primary endpoint; whereas the trial designs in the US were richer and more diverse. In addition, no BTD Chinese medicine has been approved for marketing. It is recommended that China's drug regulatory agencies learn from the US experience, formulate BTD review and management standards, strengthen the leading role of reviewers, set up interdisciplinary teams, strengthen the guidance of clinical trial development and improve the efficiency of research and development and review; at the same time, strengthen the supervision of BTD-recognised medicines after superimposed conditional approval for listing, and promote the declaration and approval of BTD traditional Chinese medicines. Pharmaceutical companies should strengthen the training of R&D teams on BTD regulations and skills, improve the quality of BTD drug applications, and promote the accelerated marketing of products to meet patients' clinical needs.

, authors=Xin WEN, Li-juan TIAN*, authorsList=Xin WEN, Li-juan TIAN, authorCompany=null, correspAuthors=Li-juan TIAN, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1321425696249987573, articleId=1321425695838945779, tenantId=1146029695717560320, journalId=1235980733773295621, language=CN, title=中美突破性治疗药物制度实施效果的比较研究, columnId=1236331162679955859, journalTitle=中国新药杂志, columnName=新药述评与论坛, runingTitle=null, highlight=null, articleAbstract=
目的:

借鉴美国突破性治疗药物(breakthrough therapy designation, BTD)制度的有益经验,为完善我国BTD制度提供建议和参考。

方法:

通过对中美BTD制度的实施效果进行比较分析,揭示两国BTD制度的实施效果与差距。

结果与结论:

中美BTD认定申请数量总体均呈增长趋势,但我国BTD认定率和认定获批率均显著低于美国,这可能与申请质量参差不齐和政策细化程度不足有关。我国BTD药物上市前临床开发时间较短,但审评时间较长,反映了两国药品监管机构在临床试验指导力度上的差异。在抗肿瘤药物临床试验设计方面,我国更倾向于单臂、非随机设计,以客观缓解率为主要终点;而美国试验设计则更为丰富与多元。此外,尚未有BTD中药获批上市。建议我国药品监管机构借鉴美国经验,制定BTD审评管理规范,加强审评人员的主导作用,设立跨学科团队,加强临床试验研制指导,提高研发及审评效率;同时,加强BTD认定药物叠加附条件批准上市后的监管,并推动BTD中药的申报与审批。医药企业应加强研发团队BTD法规和技能培训,提高BTD药物申请的质量,促进产品加快上市以满足患者临床需求。

, authors=文鑫, 田丽娟*, authorsList=文鑫, 田丽娟, authorCompany=null, correspAuthors=田丽娟, authorNote=

文鑫,女,硕士研究生,主要从事药事法规与药物政策研究。E-mail: 。

, correspAuthorsNote=
* 田丽娟,女,硕士生导师,副教授,主要从事药事法规与药物政策研究。E-mail: 。
, copyrightStatement=null, copyrightOwner=《中国新药杂志》有限公司, extLink=null, articleAbsUrl=null, sourceXml=5jO2xH/ANrrp/X4fUplsDg==, magXml=RgW25KzOq6EllEyW6ycbiw==, pdfUrl=null, pdf=LUHQkgBIMPEnB/pmNn/z7w==, pdfFileSize=2107762, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=lNdwi0DNCHEDW9tpVjmlgQ==, mapNumber=null, fund=null)}, authors=[Author(id=1321425696631669242, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=wenxin_6@126.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1321425696719749628, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, authorId=1321425696631669242, language=EN, stringName=Xin WEN, firstName=Xin, middleName=null, lastName=WEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Shenyang Pharmaceutical University, Shenyang 110016, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1321425696803635709, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, authorId=1321425696631669242, language=CN, stringName=文鑫, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=沈阳药科大学,沈阳 110016, bio={"content":"

文鑫,女,硕士研究生,主要从事药事法规与药物政策研究。E-mail: 。

"}, bioImg=null, bioContent=

文鑫,女,硕士研究生,主要从事药事法规与药物政策研究。E-mail: 。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1321425696518423030, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, xref=null, ext=[AuthorCompanyExt(id=1321425696531005943, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, companyId=1321425696518423030, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shenyang Pharmaceutical University, Shenyang 110016, China), AuthorCompanyExt(id=1321425696543588856, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, companyId=1321425696518423030, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=沈阳药科大学,沈阳 110016)])]), Author(id=1321425696887521791, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=tianlijuan_8@126.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1321425696967213569, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, authorId=1321425696887521791, language=EN, stringName=Li-juan TIAN, firstName=Li-juan, middleName=null, lastName=TIAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Shenyang Pharmaceutical University, Shenyang 110016, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1321425697030128130, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, authorId=1321425696887521791, language=CN, stringName=田丽娟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=沈阳药科大学,沈阳 110016, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1321425696518423030, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, xref=null, ext=[AuthorCompanyExt(id=1321425696531005943, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, companyId=1321425696518423030, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shenyang Pharmaceutical University, Shenyang 110016, China), AuthorCompanyExt(id=1321425696543588856, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, companyId=1321425696518423030, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=沈阳药科大学,沈阳 110016)])])], keywords=[Keyword(id=1321425697126597123, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, language=EN, orderNo=1, keyword=breakthrough therapy designation), Keyword(id=1321425697210483204, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, language=EN, orderNo=2, keyword=drug registration), Keyword(id=1321425697273397765, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, language=EN, orderNo=3, keyword=implementation effect), Keyword(id=1321425697353089542, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, language=CN, orderNo=1, keyword=突破性治疗药物), Keyword(id=1321425697428587015, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, language=CN, orderNo=2, keyword=药品注册), Keyword(id=1321425697516667400, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, language=CN, orderNo=3, keyword=实施效果)], refs=null, funds=null, companyList=[AuthorCompany(id=1321425696518423030, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, xref=null, ext=[AuthorCompanyExt(id=1321425696531005943, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, companyId=1321425696518423030, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shenyang Pharmaceutical University, Shenyang 110016, China), AuthorCompanyExt(id=1321425696543588856, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, companyId=1321425696518423030, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=沈阳药科大学,沈阳 110016)])], figs=null, attaches=null, journal=Journal(id=1235980159023624194, delFlag=0, nameCn=中国新药杂志, nameEn=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, issn=1003-3734, eissn=null, cn=11-2850/R, coden=ZXZHA6, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of New Drugs, journalRemark=null, publicationField=null, createdTime=1772610233314, updatedTime=1788948968376, createdBy=18614031015, updatedBy=13041195026, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=ohPEEN//Vz1tDT3ZBNTp4Q==, picEn=f9WK9bvTM4guTmS/iGhOMg==, jcr=null, cjcr=null, exts=[JournalExt(id=1304509780974924039, language=CN, name=中国新药杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948968404, updatedTime=1788948968404, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1304509781025255688, language=EN, name=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948968416, updatedTime=1788948968416, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1235980733773295621, websiteList=[Website(id=1235982099191222761, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/CN, language=CN, createTime=1772610695884, createBy=18614031015, updateTime=1772610860397, updateBy=18614031015, name=中国新药杂志-中文, tplId=1146099689490845704, title=中国新药杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983918629966444, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=articleTextType, value=kx, createTime=1772611129672, updateTime=1772611129672, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918604800617, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=banner, value=null, createTime=1772611129666, updateTime=1772611129666, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918655132271, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=grayFlag, value=0, createTime=1772611129678, updateTime=1772611129678, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918596412008, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611129664, updateTime=1772611129664, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918667715185, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=minRunFlag, value=0, createTime=1772611129681, updateTime=1772611129681, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918617383531, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic, createTime=1772611129669, updateTime=1772611129669, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918659326576, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=silenceFlag, value=0, createTime=1772611129679, updateTime=1772611129679, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918613189226, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1772611129668, updateTime=1772611129668, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918634160749, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeColor, value=null, createTime=1772611129673, updateTime=1772611129673, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918646743662, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeStyle, value=null, createTime=1772611129676, updateTime=1772611129676, creator=18614031015, updator=18614031015)]), Website(id=1235982099270914542, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/EN, language=EN, createTime=1772610695903, createBy=18614031015, updateTime=1772610875891, updateBy=18614031015, name=中国新药杂志-英文, tplId=1146101810881728533, title=Chinese Journal of New Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983955829248630, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=articleTextType, value=kx, createTime=1772611138541, updateTime=1772611138541, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955804082803, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=banner, value=null, createTime=1772611138535, updateTime=1772611138535, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955854414457, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=grayFlag, value=0, createTime=1772611138547, updateTime=1772611138547, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955795694194, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611138533, updateTime=1772611138533, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955866997371, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=minRunFlag, value=0, createTime=1772611138550, updateTime=1772611138550, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955820860021, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic, createTime=1772611138539, updateTime=1772611138539, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955862803066, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=silenceFlag, value=0, createTime=1772611138549, updateTime=1772611138549, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955812471412, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1772611138537, updateTime=1772611138537, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955837637239, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeColor, value=null, createTime=1772611138543, updateTime=1772611138543, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955846025848, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeStyle, value=null, createTime=1772611138545, updateTime=1772611138545, creator=18614031015, updator=18614031015)])], journalTitle=中国新药杂志, weixinUrl=null, journalUrl=http://www.newdrug.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of New Drugs, journalPhotoCn=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPhotoEn=f9WK9bvTM4guTmS/iGhOMg==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/10.20251/j.cnki.1003-3734.2026.10.004, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/10.20251/j.cnki.1003-3734.2026.10.004, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/PDF/10.20251/j.cnki.1003-3734.2026.10.004, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/PDF/10.20251/j.cnki.1003-3734.2026.10.004, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1780070400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
中美突破性治疗药物制度实施效果的比较研究
收藏切换
PDF下载
文鑫 , 田丽娟 *
中国新药杂志 | 新药述评与论坛 2026,35(10): 1032-1039
收起
收藏切换
中国新药杂志 |新药述评与论坛 2026 , 35 (10) : 1032 -1039
中美突破性治疗药物制度实施效果的比较研究
全屏
[Author(id=1321425696631669242, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=wenxin_6@126.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1321425696719749628, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, authorId=1321425696631669242, language=EN, stringName=Xin WEN, firstName=Xin, middleName=null, lastName=WEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Shenyang Pharmaceutical University, Shenyang 110016, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1321425696803635709, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, authorId=1321425696631669242, language=CN, stringName=文鑫, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=沈阳药科大学,沈阳 110016, bio={"content":"

文鑫,女,硕士研究生,主要从事药事法规与药物政策研究。E-mail: 。

"}, bioImg=null, bioContent=

文鑫,女,硕士研究生,主要从事药事法规与药物政策研究。E-mail: 。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1321425696518423030, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, xref=null, ext=[AuthorCompanyExt(id=1321425696531005943, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, companyId=1321425696518423030, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shenyang Pharmaceutical University, Shenyang 110016, China), AuthorCompanyExt(id=1321425696543588856, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, companyId=1321425696518423030, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=沈阳药科大学,沈阳 110016)])]), Author(id=1321425696887521791, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=tianlijuan_8@126.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1321425696967213569, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, authorId=1321425696887521791, language=EN, stringName=Li-juan TIAN, firstName=Li-juan, middleName=null, lastName=TIAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Shenyang Pharmaceutical University, Shenyang 110016, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1321425697030128130, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, authorId=1321425696887521791, language=CN, stringName=田丽娟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=沈阳药科大学,沈阳 110016, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1321425696518423030, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, xref=null, ext=[AuthorCompanyExt(id=1321425696531005943, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, companyId=1321425696518423030, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shenyang Pharmaceutical University, Shenyang 110016, China), AuthorCompanyExt(id=1321425696543588856, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1321425695838945779, companyId=1321425696518423030, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=沈阳药科大学,沈阳 110016)])])]
文鑫 , 田丽娟*
作者信息
  • 沈阳药科大学,沈阳 110016
通讯作者:
* 田丽娟,女,硕士生导师,副教授,主要从事药事法规与药物政策研究。E-mail: 。
作者简介:

文鑫,女,硕士研究生,主要从事药事法规与药物政策研究。E-mail: 。

A comparative study of the implementation effects of breakthrough therapeutic drug systems in China and the United States
Xin WEN , Li-juan TIAN*
Affiliations
  • Shenyang Pharmaceutical University, Shenyang 110016, China
出版时间: 2026-05-30 doi: 10.20251/j.cnki.1003-3734.2026.10.004
文章导航
收藏切换
目的:

借鉴美国突破性治疗药物(breakthrough therapy designation, BTD)制度的有益经验,为完善我国BTD制度提供建议和参考。

方法:

通过对中美BTD制度的实施效果进行比较分析,揭示两国BTD制度的实施效果与差距。

结果与结论:

中美BTD认定申请数量总体均呈增长趋势,但我国BTD认定率和认定获批率均显著低于美国,这可能与申请质量参差不齐和政策细化程度不足有关。我国BTD药物上市前临床开发时间较短,但审评时间较长,反映了两国药品监管机构在临床试验指导力度上的差异。在抗肿瘤药物临床试验设计方面,我国更倾向于单臂、非随机设计,以客观缓解率为主要终点;而美国试验设计则更为丰富与多元。此外,尚未有BTD中药获批上市。建议我国药品监管机构借鉴美国经验,制定BTD审评管理规范,加强审评人员的主导作用,设立跨学科团队,加强临床试验研制指导,提高研发及审评效率;同时,加强BTD认定药物叠加附条件批准上市后的监管,并推动BTD中药的申报与审批。医药企业应加强研发团队BTD法规和技能培训,提高BTD药物申请的质量,促进产品加快上市以满足患者临床需求。

突破性治疗药物  /  药品注册  /  实施效果
Objective:

To draw on the useful experience of the breakthrough therapy designation (BTD) system in the United States (US) to provide suggestions and references for improving the BTD system in China.

Methods:

Through a comparative analysis of the implementation effects of the BTD systems in China and the US, the implementation effects and gaps of the BTD systems in the two countries were revealed.

Results & Conclusion:

The numbers of applications for BTD recognition in China and the US were generally on the rise, but the rates of BTD recognition and approval in China were significantly lower than those in the US, which may be related to the uneven quality of the applications and the lack of policy refinement. China's BTD drugs had a shorter pre-market clinical development time, but a longer review time, reflecting the difference in the strength of clinical trial guidance between the two countries' drug regulatory agencies. In terms of clinical trial design for antitumour drugs, China preferred single-arm, non-randomised design with objective remission rate as the primary endpoint; whereas the trial designs in the US were richer and more diverse. In addition, no BTD Chinese medicine has been approved for marketing. It is recommended that China's drug regulatory agencies learn from the US experience, formulate BTD review and management standards, strengthen the leading role of reviewers, set up interdisciplinary teams, strengthen the guidance of clinical trial development and improve the efficiency of research and development and review; at the same time, strengthen the supervision of BTD-recognised medicines after superimposed conditional approval for listing, and promote the declaration and approval of BTD traditional Chinese medicines. Pharmaceutical companies should strengthen the training of R&D teams on BTD regulations and skills, improve the quality of BTD drug applications, and promote the accelerated marketing of products to meet patients' clinical needs.

breakthrough therapy designation  /  drug registration  /  implementation effect
文鑫, 田丽娟. 中美突破性治疗药物制度实施效果的比较研究. 中国新药杂志, 2026 , 35 (10) : 1032 -1039 . DOI: 10.20251/j.cnki.1003-3734.2026.10.004
Xin WEN, Li-juan TIAN. A comparative study of the implementation effects of breakthrough therapeutic drug systems in China and the United States[J]. Chinese Journal of New Drugs, 2026 , 35 (10) : 1032 -1039 . DOI: 10.20251/j.cnki.1003-3734.2026.10.004

参考文献 引证文献
排序方式:
2026年第35卷第10期
PDF下载
39
7
引用本文
BibTeX
文章信息
doi: 10.20251/j.cnki.1003-3734.2026.10.004
  • 首发时间:2026-10-26
  • 出版时间:2026-05-30
补充材料
相关文章
文章信息
作者
出版历史
  • 录用日期:2025-07-06
基金
作者信息
    沈阳药科大学,沈阳 110016

通讯作者:

* 田丽娟,女,硕士生导师,副教授,主要从事药事法规与药物政策研究。E-mail: 。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgxyzz/CN/10.20251/j.cnki.1003-3734.2026.10.004
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏